 Shares of Inogen NASDAQ:INGN were flat in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share were down 73.33 over the past year to 0.12, which beat the estimate of 0.06.Revenue of 71,691,000 declined by 29.06 from the same period last year, which missed the estimate of 79,960,000.Guidance Earnings guidance hasnt been issued by the company for now.Inogen hasnt issued any revenue guidance for the time being.Details Of The Call Date: Aug 04, 2020View more earnings on INGNTime: 04:30 PMET Webcast URL: Stock Performance Companys 52-week high was at 76.89Companys 52-week low was at 29.28Price action over last quarter: down 22.44Company Profile Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. The majority of rental revenue comes from Medicare service reimbursement programs. Internationally, Inogen sells its products through distributors or large gas companies and home oxygen providers. Inogen generates the majority of its revenue in the United States.See more from Benzinga Stocks That Hit 52-Week Lows On Monday Benzingas Top Upgrades, Downgrades For June 11, 2020C 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 